The Value of Pharmacogenomic Information
NBER Working Paper No. 24134
---- Acknowledgments ----
We thank Jonathan Schildcrout, Yaping Shi, Dan Roden, Josh Denny, Ramya Marathi, Cassie Smith, Rafael Tamargo, and Katie Doherty for generous contributions to this project. We are grateful also for thoughtful comments from seminar participants at Vanderbilt, the National Institutes of Health, and the NBER Program on Economic Dimensions of Personalized and Precision Medicine. Generous support for this work was provided by the National Institutes of Health grants 1U01HL122904-01 and 1R01HG009694-01. The views expressed herein are those of the authors and do not necessarily reflect the views of the National Bureau of Economic Research.